A detailed history of Primecap Management CO transactions in Glaukos Corp stock. As of the latest transaction made, Primecap Management CO holds 1,220,815 shares of GKOS stock, worth $164 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
1,220,815
Previous 848,635 43.86%
Holding current value
$164 Million
Previous $80 Million 80.57%
% of portfolio
0.11%
Previous 0.06%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$89.48 - $118.35 $33.3 Million - $44 Million
372,180 Added 43.86%
1,220,815 $144 Million
Q1 2024

May 13, 2024

BUY
$76.4 - $96.33 $4.48 Million - $5.64 Million
58,600 Added 7.42%
848,635 $80 Million
Q4 2023

Feb 09, 2024

BUY
$59.53 - $85.11 $9.01 Million - $12.9 Million
151,415 Added 23.71%
790,035 $62.8 Million
Q3 2023

Nov 13, 2023

BUY
$69.23 - $79.09 $1.39 Million - $1.59 Million
20,120 Added 3.25%
638,620 $48.1 Million
Q2 2023

Aug 11, 2023

BUY
$45.44 - $71.21 $468,032 - $733,462
10,300 Added 1.69%
618,500 $44 Million
Q1 2023

May 15, 2023

BUY
$43.88 - $52.48 $2.53 Million - $3.03 Million
57,720 Added 10.49%
608,200 $30.5 Million
Q4 2022

Feb 13, 2023

BUY
$40.82 - $57.75 $513,923 - $727,072
12,590 Added 2.34%
550,480 $24 Million
Q3 2022

Nov 14, 2022

SELL
$46.84 - $58.49 $163,003 - $203,545
-3,480 Reduced 0.64%
537,890 $28.6 Million
Q2 2022

Aug 11, 2022

BUY
$34.86 - $63.77 $309,208 - $565,639
8,870 Added 1.67%
541,370 $24.6 Million
Q1 2022

May 11, 2022

SELL
$44.33 - $57.82 $17,732 - $23,128
-400 Reduced 0.08%
532,500 $30.8 Million
Q4 2021

Feb 11, 2022

BUY
$40.27 - $56.99 $1.32 Million - $1.86 Million
32,700 Added 6.54%
532,900 $23.7 Million
Q3 2021

Nov 12, 2021

BUY
$47.43 - $84.23 $2.64 Million - $4.69 Million
55,700 Added 12.53%
500,200 $24.1 Million
Q2 2021

Aug 10, 2021

BUY
$73.06 - $97.7 $599,092 - $801,140
8,200 Added 1.88%
444,500 $37.7 Million
Q1 2021

May 14, 2021

BUY
$70.43 - $97.42 $359,193 - $496,842
5,100 Added 1.18%
436,300 $36.6 Million
Q4 2020

Feb 08, 2021

BUY
$48.9 - $75.26 $1.15 Million - $1.77 Million
23,500 Added 5.76%
431,200 $32.5 Million
Q3 2020

Nov 13, 2020

BUY
$37.23 - $50.97 $225,986 - $309,387
6,070 Added 1.51%
407,700 $20.2 Million
Q2 2020

Aug 13, 2020

BUY
$28.78 - $46.83 $1.78 Million - $2.9 Million
61,930 Added 18.23%
401,630 $15.4 Million
Q1 2020

May 14, 2020

BUY
$25.53 - $70.14 $548,895 - $1.51 Million
21,500 Added 6.76%
339,700 $10.5 Million
Q4 2019

Feb 14, 2020

BUY
$54.18 - $65.64 $1.95 Million - $2.36 Million
35,900 Added 12.72%
318,200 $17.3 Million
Q3 2019

Nov 13, 2019

BUY
$58.58 - $83.91 $562,368 - $805,536
9,600 Added 3.52%
282,300 $17.6 Million
Q1 2019

May 14, 2019

BUY
$50.75 - $80.54 $203,000 - $322,160
4,000 Added 1.49%
272,700 $21.4 Million
Q4 2018

Feb 12, 2019

SELL
$52.18 - $67.93 $15,654 - $20,379
-300 Reduced 0.11%
268,700 $15.1 Million
Q3 2018

Nov 13, 2018

BUY
$38.13 - $68.37 $2.08 Million - $3.73 Million
54,500 Added 25.41%
269,000 $17.5 Million
Q2 2018

Aug 13, 2018

BUY
$27.62 - $44.51 $897,650 - $1.45 Million
32,500 Added 17.86%
214,500 $8.72 Million
Q1 2018

May 14, 2018

BUY
$26.05 - $34.5 $2.6 Million - $3.44 Million
99,790 Added 121.38%
182,000 $5.61 Million
Q4 2017

Feb 13, 2018

BUY
$24.5 - $36.01 $2.01 Million - $2.96 Million
82,210
82,210 $2.11 Million

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $6.38B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Primecap Management CO Portfolio

Follow Primecap Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Primecap Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Primecap Management CO with notifications on news.